| Compound Information | SONAR Target prediction | | Name: | 5alpha-ANDROSTAN-3,17-DIONE | | Unique Identifier: | SPE00107108 | | MolClass: | Checkout models in ver1.5 and ver1.0 | | Molecular Formula: | | | Molecular Weight: | 261.21 g/mol | | X log p: | -0.364 (online calculus) | | Lipinksi Failures | 0 | | TPSA | 34.14 | | Hydrogen Bond Donor Count: | 0 | | Hydrogen Bond Acceptors Count: | 2 | | Rotatable Bond Count: | 0 | | Canonical Smiles: | CC12CCC(=O)CC1CCC1C2CCC2(C)C1CCC2=O | | Class: | sterol | | Source: | human urine & adrenal cortex | | Therapeutics: | androgen | | Generic_name: | 5ALPHA-ANDROSTAN-3,17-DIONE | | Chemical_iupac_name: | 5ALPHA-ANDROSTAN-3,17-DIONE | | Drug_type: | Experimental | | Drugbank_id: | EXPT00262 | | Drug_category: | Estradiol 17 Beta-Dehydrogenase 1 inhibitor | | Organisms_affected: | -1 |
| Species: |
4932 |
| Condition: |
GBP2 |
| Replicates: |
2 |
| Raw OD Value: r im |
0.6160±0.0211425 |
| Normalized OD Score: sc h |
0.8599±0.0146735 |
| Z-Score: |
-6.1326±0.51062 |
| p-Value: |
0.0000000039697 |
| Z-Factor: |
0.0859539 |
| Fitness Defect: |
19.3446 |
| Bioactivity Statement: |
Active |
| Experimental Conditions | | | Library: | SPECMTS3 | | Plate Number and Position: | 9|C8 | | Drug Concentration: | 50.00 nM | | OD Absorbance: | 600 nm | | Robot Temperature: | 23.80 Celcius | | Date: | 2008-03-26 YYYY-MM-DD | | Plate CH Control (+): | 0.040225±0.00075 | | Plate DMSO Control (-): | 0.702625±0.01949 | | Plate Z-Factor: | 0.9188 |
|  png
ps
pdf |
| 7004919 |
(2S)-2-tert-butylcyclohexan-1-one |
| 7006386 |
(2R,6S)-2,6-dimethyl-4-[(1R,2S,4R)-norbornan-2-yl]cyclohexan-1-one |
| 7007034 |
n/a |
| 7008249 |
(2S,3R,5S)-3,5-dimethyl-2-[(1R,2S,4R)-norbornan-2-yl]cyclohexan-1-one |
| 7009232 |
n/a |
| 7015131 |
(3S)-3-ethylcyclopentan-1-one |
| internal high similarity DBLink | Rows returned: 17 | 1 2 3 Next >> |
| active | Cluster 11774 | Additional Members: 14 | Rows returned: 5 | |
|
